Clinical Trial Update: A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma [Phase 2]

View source ↗

Summary

This Phase 2 study compares continuous bevacizumab (Avastin) versus placebo, in addition to lomustine, for glioblastoma after progression. The trial status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)
• CeeNU (lomustine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED